666 related articles for article (PubMed ID: 24022702)
1. Emerging patterns of somatic mutations in cancer.
Watson IR; Takahashi K; Futreal PA; Chin L
Nat Rev Genet; 2013 Oct; 14(10):703-18. PubMed ID: 24022702
[TBL] [Abstract][Full Text] [Related]
2. Beyond the exome: the role of non-coding somatic mutations in cancer.
Piraino SW; Furney SJ
Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis of whole genomes.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Sequencing.
Le Gallo M; Lozy F; Bell DW
Adv Exp Med Biol; 2017; 943():119-148. PubMed ID: 27910067
[TBL] [Abstract][Full Text] [Related]
5. Advances in understanding cancer genomes through second-generation sequencing.
Meyerson M; Gabriel S; Getz G
Nat Rev Genet; 2010 Oct; 11(10):685-96. PubMed ID: 20847746
[TBL] [Abstract][Full Text] [Related]
6. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F; Zhao J; Zhao Z
Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
[TBL] [Abstract][Full Text] [Related]
7. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
Van Allen EM; Robinson D; Morrissey C; Pritchard C; Imamovic A; Carter S; Rosenberg M; McKenna A; Wu YM; Cao X; Chinnaiyan A; Garraway L; Nelson PS
Oncotarget; 2016 Aug; 7(33):52888-52899. PubMed ID: 27167109
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
9. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
[TBL] [Abstract][Full Text] [Related]
10. Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing.
Yang L; Lee MS; Lu H; Oh DY; Kim YJ; Park D; Park G; Ren X; Bristow CA; Haseley PS; Lee S; Pantazi A; Kucherlapati R; Park WY; Scott KL; Choi YL; Park PJ
Am J Hum Genet; 2016 May; 98(5):843-856. PubMed ID: 27153396
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.
Murtaza M; Dawson SJ; Tsui DW; Gale D; Forshew T; Piskorz AM; Parkinson C; Chin SF; Kingsbury Z; Wong AS; Marass F; Humphray S; Hadfield J; Bentley D; Chin TM; Brenton JD; Caldas C; Rosenfeld N
Nature; 2013 May; 497(7447):108-12. PubMed ID: 23563269
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing.
Hoang ML; Kinde I; Tomasetti C; McMahon KW; Rosenquist TA; Grollman AP; Kinzler KW; Vogelstein B; Papadopoulos N
Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9846-51. PubMed ID: 27528664
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutation load and spectra: A record of DNA damage and repair in healthy human cells.
Saini N; Gordenin DA
Environ Mol Mutagen; 2018 Oct; 59(8):672-686. PubMed ID: 30152078
[TBL] [Abstract][Full Text] [Related]
14. Deep sequencing in cancer research.
Yoshida K; Sanada M; Ogawa S
Jpn J Clin Oncol; 2013 Feb; 43(2):110-5. PubMed ID: 23225907
[TBL] [Abstract][Full Text] [Related]
15. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
[TBL] [Abstract][Full Text] [Related]
16. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
17. Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
[TBL] [Abstract][Full Text] [Related]
18. An Individualized Approach for Somatic Variant Discovery.
Li M; He T; Cao C; Long Q
Methods Mol Biol; 2020; 2120():11-36. PubMed ID: 32124309
[TBL] [Abstract][Full Text] [Related]
19. Genomic sequencing in cancer.
Tuna M; Amos CI
Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448
[TBL] [Abstract][Full Text] [Related]
20. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data.
do Valle ÍF; Giampieri E; Simonetti G; Padella A; Manfrini M; Ferrari A; Papayannidis C; Zironi I; Garonzi M; Bernardi S; Delledonne M; Martinelli G; Remondini D; Castellani G
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):341. PubMed ID: 28185561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
